What to Expect: Screening For Diabetic Neuropathy
Conquest Research is dedicated to supporting individuals living with Diabetic Peripheral Neuropathy (DPN) by offering clinical trials focused on advancing potential treatment options. Participant safety is our top priority, and all volunteers complete a comprehensive screening process to determine eligibility. This screening process includes:
Diabetic Peripheral Neuropathy (DPN) is a common result of diabetes that causes symptoms such as numbness, tingling, burning sensations, pain, or weakness in the affected areas. While there is no cure for DPN, clinical research is an option to potentially help manage symptoms, improve quality of life, and slow the progression of nerve damage.


Qualifications For A Diabetic Neuropathy Clinical Trial:
As a participant in our clinical trial, certain eligibility criteria must be met. If you qualify, we invite you to consider participating and helping advance the development of potential new treatments.
You may be eligible to participate if you:
– Have been diagnosed with Type 1 or 2 Diabetes
– Are currently on stable diabetes medication
– Have been experiencing diabetic nerve pain
*Other inclusion criteria may apply
Reasons to Join A DPN Ensayo clínico
In addition to improving your quality of life and supporting the development of new treatments, participating in a clinical trial may offer additional benefits for participants.
Frequently Asked Questions About A Diabetic Neuropathy Clinical Trial


Join an Diabetic Neuropathy Clinical Trial Today!
Join our DPN clinical trial and help advance potential new treatment options. Complete the form today to see if you qualify.




